https://www.selleckchem.com/pr....oducts/Adriamycin.ht
6 (1.2-5.8) and 2.5 (1.3-5.2), respectively), whereas levetiracetam intake reduces the risk of nonadherence (OR 0.5 [0.2-0.9]). The prevalence of AED adherence was 70.8%. Education level and having a seizure in the last 6 months were significant predictors of nonadherence, whereas levetiracetam intake reduces the risk of nonadherence. The prevalence of AED adherence was 70.8%. Education level and having a seizure in the last 6 months were significant predictors of nonadherence, whereas levetiracetam intake reduces the risk of nonadhe
Like
Comment
Share
